Cleveland Clinic Cardiovascular Update 2025

Overview

The Cleveland Clinic Cardiovascular Update 2025 is a comprehensive educational experience designed for healthcare professionals dedicated to advancing excellence in cardiovascular medicine. This expertly curated program brings together leading experts to address the most current practices, innovations, and controversies in cardiovascular prevention, diagnosis, and management. Through high-impact sessions covering prevention, risk reduction, special populations, structural heart disease, heart failure, and heart rhythm disorders, you will gain actionable insights grounded in evidence and clinical relevance. World-Class Medical Learning — Accessible anytime, anywhere—ensures you stay at the forefront of cardiovascular care, regardless of your schedule or location.

Learning Objectives

By the end of this course, participants will be able to:

• Incorporate the latest evidence-based strategies for the prevention and management of cardiovascular risk.
• Apply new approaches in lipid management, antihyperglycemic therapy, and weight loss pharmacotherapy.
• Evaluate and manage cardiovascular disease in special populations, including women, athletes, and pregnant patients.
• Implement emerging best practices in the management of structural heart disease, heart failure, and rhythm disorders.
• Leverage advanced imaging and diagnostic modalities for comprehensive patient assessment.
• Navigate the complexities of comorbidities, resistant hypertension, geriatric cardiology, and cardio-oncology.
• Enhance patient outcomes through multidisciplinary and population health strategies.

Topics

• Session 1: Prevention and Management of Cardiovascular Risk, Part 1
• Tools in CVD Prevention and Risk Management: To Test or Not to Test? Lp(a), apoB, Non HDL-C
• Statin Initiation for Primary Prevention Among Statin Naïve Adults and Reasons for Nonadherence
• When Statins Are Not Enough – Non-statin Lipid Lowering Therapies to Manage Residual Risk
• Managing Anti-Hyperglycemic and CV Risk Reduction Agents in Patients With Diabetes: SGLT2i or GLP1RA or Both?
• Weight Loss Pharmacotherapy: Utilizing Current Therapies and Exploring the Next Generation of Weight Loss Medications
• Keto, Low Carb, Plant Based, IF: Controversies in the Evidence for the “Best “Diet: What is the Evidence and How to Apply in Clinical Practice
• Old and Evolving Strategies for Treatment-Resistant Hypertension
• Social Determinants of Health and Cardiovascular Disease: Current State and Future Directions
• Panel Discussion/Q&A
• Session 2: Prevention and Management of Cardiovascular Risk, Part 2
• Hormone Therapy and Heart Health: Debunking Myths, Embracing Evidence
• The Intersection of Cardiovascular Disease and Chronic Kidney Disease: Strategies for Reducing Cardiovascular Risk
• Who Should Get a CAC? How Often? How to Use the Results to Assess Risk?
• Management of CV Issues in the Elderly: Geriatric Cardiology
• Population Health Management: Interventions to Control Cardiovascular Disease Risk Factors: Current Status
• Panel Discussion/Q&A
• Session 3: Special Populations
• Cardiac Disease Remains the Leading Cause of Mortality in Women: What are we Doing to Address This?
• Cardiovascular Disease and Pregnancy: Optimizing Maternal and Fetal Health
• Competitive Sports Participation in Athletes with Heart Disease: Evaluation and Management
• Cardio-oncology: Optimizing the Balance Between Cancer Outcomes and Cardiac Success
• Panel Discussion/Q&A
• Session 4: Essentials of Cardiovascular Disease
• Role of Advanced Imaging for Ischemic Heart Disease: CT, CMR, Nuclear and Advanced Echocardiography
• Creating a Pathway for the Management of Stable Angina in Your Clinic: Structured Risk Assessment and Clinical Decision Making
• ANOCA, INOCA, MINOCA: What Does It All Mean? Diagnostic Testing and Therapeutic Management
• How Do I Manage my Post MI Patient (Including DAPT Guidelines/Duration/CardiacRehab)
• Cardiac Rehab: Why it is Critical and How Can We Improve Access and Compliance?
• Peripheral Artery Disease: Assessment and Clinical Decision Making
• Panel Discussion/Q&A
• Session 5: Structural Heart Disease
• Aortic Stenosis: Diagnosis and Management in the Modern Era
• MR: How to Diagnose and Manage Mitral Valve Disease: When to Refer? What are the Options
• What to Know About the Natural History of Tricuspid Regurgitation: Current and Future Management Strategies
• Bicuspid and Aneurysm-Associated Aortic Valve Disease: Timing of Intervention and the Role of Family Screening
• Guidelines for Anticoagulation Following Structural Heart Therapies
• Hypertrophic Cardiomyopathy: Co-management in the Era of Emerging Precision Therapies
• Panel Discussion/Q&A
• Session 6: Heart Failure
• Heart Failure Stages, Phenotypes and Diagnosis and How to Screen for HF in the Primary Care Setting
• HFrEF: Essentials of Guideline Directed Medical Therapy Initiation and Titration
• Managing Comorbidities in HF: Frailty, Anemia, Sleep Apnea, AF, Obesity
• Essentials of Diagnosis and Management for HFpEF
• Diagnosis and Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
• Strategies to Enhance GDMT Implementation and Adherence
• Managing Long Term LVADs and Transplant Recipients in the Community Setting
• The Importance of Collaboration Between EP and HF: CRT and Novel Pacing
• Panel Discussion/Q&A
• Session 7: Heart Rhythm
• Diagnosis and Management of New-Onset Atrial Fibrillation
• AF and Left Atrial Appendage Closure: Current and Future Directions
• What I Need to Know to Evaluate and Manage the Patient With PVCs and SVT
• Evaluation and Management of Syncope in the Young Adult
• Follow-Up of Pacemakers and ICDs For the Non-Electrophysiologist
• Wearables for Arrhythmia Care: Current Challenges and Future Prospects
• Panel Discussion/Q&A

Target Audience

This course is designed for healthcare professionals involved in cardiovascular care who are seeking to expand their clinical expertise and keep pace with evolving standards.

• Cardiologists
• Internal Medicine Physicians
• Primary Care Providers
• Nurse Practitioners
• Physician Assistants
• Fellows and Residents
• Pharmacists
• Nurses
• Dietitians involved in cardiovascular patient care
• Other allied health professionals interested in cardiovascular medicine

Speakers

• Dennis Bruemmer, MD, PhD
• Vikas Sunder, MD
• Ashish Sarraju, MD
• Steve Nissen, MD
• Julia Zumpano, RD, LD
• Luke Laffin, MD
• Lee Kirksey, MD
• Crystal Gadegbeku, MD
• Milind Desai, MD
• Ardeshir Hashmi, MD
• LeRoi Hicks, MD
• Deirdre Mattina, MD
• Tamanna Singh, MD
• Patrick Collier, MD, PhD
• Saberio Lo Presti Vega, MD
• Ben Alencherry, MD
• Khalid Ziada, MD
• Venu Menon, MD
• Erik Van Iterson, PhD, MS
• Samir Kapadia, MD
• L. Leonardo Rodriguez, MD
• Amar Krishnaswamy, MD
• Grant Reed, MD, MSc
• Randall Starling, MD
• Amanda Vest, MBBS
• Karlee Hoffman, DO
• Sanjeeb Bhattacharya, MD
• Mazen Hanna, MD
• M. Trejeeve Martyn, MD
• Ike Okwuosa, MD
• Niraj Varma, MD, PhD
• Mohamed Kanj, MD
• Pasquale Santangeli, MD, PhD
• Kenneth Mayuga, MD
• Kevin F. Kwaku, MD, PhD
• Session Faculty

This diverse panel consists of highly experienced clinicians, researchers, and allied health professionals dedicated to delivering world-class cardiovascular education and sharing practical expertise to support your medical learning journey.

Educational content only. Not medical advice.